Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique C Valla

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Hepatology|December 15, 2010
Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndromeSimone Talens, Jildou Hoekstra, Steffen P G Dirkx, et al.
The American Journal of Gastroenterology|April 2, 2009
Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual managementPierre-Emmanuel Rautou, Rami Moucari, Sylvie Escolano, et al.
Blood|March 3, 2011
The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosisJasper H Smalberg, Edith Koehler, Sarwa Darwish Murad, et al.
Haematologica|February 16, 2015
Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosisElisabeth P C Plompen, Peter J M Valk, Isabel Chu, et al.
Thrombosis and Haemostasis|January 12, 2013
Fibrinogen γ' and variation in fibrinogen gamma genes in the etiology of portal vein thrombosisJasper H Smalberg, Edith Koehler, Sarwa Darwish Murad, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
Good long-term outcome of Budd-Chiari syndrome with a step-wise managementSusana Seijo, Aurelie Plessier, Jildou Hoekstra, et al.
Blood|December 8, 2009
Impaired fibrinolysis as a risk factor for Budd-Chiari syndromeJildou Hoekstra, Ana H C Guimarães, Frank W G Leebeek, et al.
Blood|February 6, 2008
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 casesJean-Jacques Kiladjian, Francisco Cervantes, Franck W G Leebeek, et al.
Annals of Internal Medicine|August 5, 2009
Etiology, management, and outcome of the Budd-Chiari syndromeSarwa Darwish Murad, Aurelie Plessier, Manuel Hernandez-Guerra, et al.
Journal of Clinical and Experimental Hepatology|March 11, 2015
Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liverRadha K Dhiman, Vivek A Saraswat, Dominique C Valla, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Hepatology|December 15, 2010
Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndromeSimone Talens, Jildou Hoekstra, Steffen P G Dirkx, et al.
The American Journal of Gastroenterology|April 2, 2009
Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual managementPierre-Emmanuel Rautou, Rami Moucari, Sylvie Escolano, et al.
Blood|March 3, 2011
The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosisJasper H Smalberg, Edith Koehler, Sarwa Darwish Murad, et al.
Haematologica|February 16, 2015
Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosisElisabeth P C Plompen, Peter J M Valk, Isabel Chu, et al.
Thrombosis and Haemostasis|January 12, 2013
Fibrinogen γ' and variation in fibrinogen gamma genes in the etiology of portal vein thrombosisJasper H Smalberg, Edith Koehler, Sarwa Darwish Murad, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
Good long-term outcome of Budd-Chiari syndrome with a step-wise managementSusana Seijo, Aurelie Plessier, Jildou Hoekstra, et al.
Blood|December 8, 2009
Impaired fibrinolysis as a risk factor for Budd-Chiari syndromeJildou Hoekstra, Ana H C Guimarães, Frank W G Leebeek, et al.
Blood|February 6, 2008
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 casesJean-Jacques Kiladjian, Francisco Cervantes, Franck W G Leebeek, et al.
Annals of Internal Medicine|August 5, 2009
Etiology, management, and outcome of the Budd-Chiari syndromeSarwa Darwish Murad, Aurelie Plessier, Manuel Hernandez-Guerra, et al.
Journal of Clinical and Experimental Hepatology|March 11, 2015
Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liverRadha K Dhiman, Vivek A Saraswat, Dominique C Valla, et al.
Pageof 3